DHA hospitals face $35.5bn Southeast Asia leakage risk as Bangkok courts UAE patients

Bangkok is pulling UAE patients toward a Southeast Asia medical tourism market forecast to reach $35.5 billion by 2034, forcing DHA, DOH and MOHAP operators to defend elective self-pay care.

For CEOs, CMOs and COOs, the commercial question is direct: which procedures are leaving the UAE, which patient segments are comparing packages abroad, and which providers can respond before a patient books a flight.

What the report says

Travel And Tour World reported on 19 June 2026 that patients from the UAE, Saudi Arabia, Qatar, India, the UK, Germany, Australia and China are contributing to medical travel into Bangkok. The report named Emirates, Qatar Airways, Etihad Airways, Singapore Airlines, Thai Airways and Turkish Airlines as carriers supporting patient arrivals into Thailand, but it did not publish UAE patient counts.

A separate IMARC Group forecast puts the Southeast Asia medical tourism market at $6.1 billion in 2025, rising to $35.5 billion by 2034. IMARC Group gives the market a 21.68% compound annual growth rate for 2026-2034.

• Thailand, Malaysia and Singapore are core destinations in the IMARC Group forecast.
• Cosmetic, dental, cardiovascular, orthopaedic, fertility and ophthalmic treatments are listed treatment categories.
• 2025 market size is $6.1 billion; 2034 forecast size is $35.5 billion.
• 21.68% is the stated CAGR for 2026-2034.

Why UAE operators should care

For Dubai providers, the relevant regulator is the Dubai Health Authority (DHA). DHA runs the DXH group membership service, which lets hospitals and clinics under DHA jurisdiction participate in Dubai's medical tourism project. DHA lists the service as available 24 hours a day, 7 days a week, with no fee for the membership service.

In Abu Dhabi and Al Ain, the regulator is the Department of Health Abu Dhabi (DOH). For Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the federal regulator is the Ministry of Health and Prevention (MOHAP). Those regulators set the licensing, advertising, clinical governance and continuity-of-care rules for UAE operators that market to medical travellers.

The airline channel is material. Etihad Airways signed a memorandum of cooperation with the Tourism Authority of Thailand on 29 April 2025. Etihad Airways said it would add Krabi and Chiang Mai in 2025, alongside Bangkok and Phuket, giving the Abu Dhabi carrier 4 Thailand gateways.

"Thailand is a very important market for Etihad." Antonoaldo Neves, chief executive officer, Etihad Airways.

What changes for commercial teams

The risk for UAE hospitals is selective leakage. They may keep emergency, chronic and insurer-directed care, while losing self-pay procedures where patients compare package price, hotel quality and recovery support. Elective self-pay work matters because it can carry higher margins than regulated insured outpatient activity.

CMOs should treat Thailand as a competitor in search, social media and referral partnerships. A Bangkok hospital selling a bundled orthopaedic, dental or cosmetic pathway competes with DHA, DOH and MOHAP-licensed providers before the patient enters a UAE clinic. The patient journey starts with price discovery, airline access and perceived clinical trust.

COOs need to check whether their facilities can answer a medical tourist query within 24 hours, issue a quote with physician review, handle medical records securely and support follow-up after discharge. CIOs should check whether CRM, call centre, consent and imaging workflows can support Arabic, English and Russian-speaking patient pathways without manual workarounds.

The next signal to watch is whether UAE regulators and tourism authorities publish fresh medical tourism targets in 2026. If Dubai or Abu Dhabi responds with faster medical visas, airline-hospital packages or new DXH-style participation rules, providers with ready pricing, referral dashboards and post-treatment protocols will move first.